Company Information
- Type:
- SME
- Country:
- Spain
- Sector:
- Pharmaceuticals & Biotechnology
- Ownership:
- Publicly Listed
- Global Compact Status:
- Active
- Participant Since
- 17 September 2024 Letter of Commitment
- Next Communication on Progress (COP) due on:
- 31 July 2025
Parent Company
Country | Company Name |
---|---|
Japan | Daiichi Sankyo Co. Ltd. |
Parent Communication On Progress
Published On | Title | Level/Status |
---|---|---|
30-Jun-2024 | 2024 Communication on Progress | Submitted |
29-Nov-2023 | 2023 Communication on Progress | Submitted |
23-Dec-2022 | Daiichi Sankyo Group Value Report 2022 | Advanced |
25-Dec-2021 | Communication on Progress | Advanced |
25-Dec-2020 | Daiichi Sankyo Group Value Report 2020 | Advanced |
26-Dec-2019 | Daiichi Sankyo Group Value Report 2019 | Advanced |
26-Dec-2018 | Daiichi Sankyo Group Value Report 2018 | Advanced |
26-Dec-2017 | Communication on Progress | Advanced |
26-Dec-2016 | Communication on Progress | Advanced |
24-Dec-2015 | Communication on Progress | Advanced |
25-Dec-2014 | Value Report 2014 | Advanced |
26-Dec-2013 | Value Report 2013 | Advanced |
25-Feb-2013 | Communication on Progress | Advanced |